Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 1% for Acute Blunt Soft Tissue Injuries
NCT02290821Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in soft tissue injury comparing diclofenac sodium gel 1% with Placebo (2 arms). Primary endpoint: Sum of Pain Intensity Differences Over 24 Hours After Initiating Treatment. Started Dec 2014; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
soft tissue injury
Beyond the preview
Go deeper on NCT02290821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290821.